genOway Société anonyme (EPA:ALGEN)
2.980
-0.200 (-6.29%)
Sep 26, 2025, 2:29 PM CET
genOway Société anonyme Revenue
genOway Société anonyme had revenue of 14.30M EUR in the half year ending December 31, 2024, with 28.92% growth. This brings the company's revenue in the last twelve months to 27.18M, down -3.21% year-over-year. In the year 2024, genOway Société anonyme had annual revenue of 27.53M with 3.85% growth.
Revenue (ttm)
27.18M
Revenue Growth
-3.21%
P/S Ratio
1.01
Revenue / Employee
192.77K
Employees
141
Market Cap
27.48M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 27.53M | 1.02M | 3.85% |
Dec 31, 2023 | 26.51M | 5.26M | 24.76% |
Dec 31, 2022 | 21.25M | 1.46M | 7.38% |
Dec 31, 2021 | 19.79M | 3.47M | 21.30% |
Dec 31, 2020 | 16.31M | 2.04M | 14.26% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
EssilorLuxottica Société anonyme | 27.24B |
Sanofi | 45.74B |
Sartorius Stedim Biotech | 2.90B |
bioMérieux | 4.12B |
Eurofins Scientific SE | 7.14B |
Ipsen | 3.76B |
ABIVAX Société Anonyme | 6.02M |
Virbac | 1.43B |